Cargando…
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
Pancreatic ductal adenocarcinoma is one of the most lethal types of tumour, and its incidence is rising worldwide. Although survival can be improved when these tumours are detected at an early stage, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis. The onl...
Autores principales: | Martinez-Useros, Javier, Garcia-Foncillas, Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023838/ https://www.ncbi.nlm.nih.gov/pubmed/27689078 http://dx.doi.org/10.1155/2016/4873089 |
Ejemplares similares
-
The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer
por: Martinez-Useros, Javier, et al.
Publicado: (2016) -
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
por: Martinez-Useros, Javier, et al.
Publicado: (2017) -
The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
por: Martinez-Useros, Javier, et al.
Publicado: (2021) -
Obesity and colorectal cancer: molecular features of adipose tissue
por: Martinez-Useros, Javier, et al.
Publicado: (2016) -
New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review
por: Garcia-Carbonero, Nuria, et al.
Publicado: (2018)